Literature DB >> 24899975

Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma.

Bong-Hoi Choi1, Hee-Sung Song1, Young-Sil An1, Sang-Uk Han2, Jang-Hee Kim3, Joon-Kee Yoon1.   

Abstract

PURPOSE: Gastric signet ring cell carcinoma (GSRC) is known to have low fluorodeoxyglucose (FDG) uptake. The aim of the study was to investigate the relation between FDG uptake and glucose transporter (GLUT)-1 expression and clinicopathologic parameters in cases of GSRC.
MATERIALS AND METHODS: Forty patients (28 men, mean age 54 ± 12 years) with histologically confirmed GSRC who underwent pre-operative [(18)F]FDG PET/CT were enrolled. Maximum standardized uptake values (SUVmax) were compared with clinicopathologic parameters and GLUT-1 expression. Cases were divided based on GLUT-1 expression in tumor tissues into a membranous group (n = 17) and a cytoplasmic group (n = 23).
RESULTS: Mean SUVmax was significantly higher in the membranous group than in the cytoplasmic group (6.06 ± 2.79 vs. 3.67 ± 1.54, P = 0.03). Gastric wall invasion, depth of invasion, extent of LN metastasis, overall stage, and tumor size were found to be related to SUVmax. On the other hand, age, sex, and the presence of distant metastasis were not related to SUVmax. Multivariate analysis revealed that membranous GLUT-1 expression and the extent of LN metastasis independently predicted high FDG uptake.
CONCLUSIONS: This study demonstrates that high FDG uptake is mediated by membranous GLUT-1 expression in GSRC.

Entities:  

Keywords:  FDG; Glucose transporter-1; Signet ring cell; Stomach cancer

Year:  2010        PMID: 24899975      PMCID: PMC4042955          DOI: 10.1007/s13139-010-0058-4

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  25 in total

1.  Early gastric carcinoma with signet ring cell histology.

Authors:  Woo Jin Hyung; Sung Hoon Noh; Jun Ho Lee; Jihun J Huh; Ki Hyeok Lah; Seung Ho Choi; Jin Sik Min
Journal:  Cancer       Date:  2002-01-01       Impact factor: 6.860

2.  FDG-negative signet ring cell cancer of the stomach with FDG-positive skin metastases.

Authors:  Ujval Bhure; Anja M Schmitt; Bernhard C Pestalozzi; Thomas F Hany; Klaus Strobel
Journal:  Clin Nucl Med       Date:  2007-03       Impact factor: 7.794

Review 3.  PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.

Authors:  Keigo Endo; Noboru Oriuchi; Tetsuya Higuchi; Yasuhiko Iida; Hirofumi Hanaoka; Mitsuyuki Miyakubo; Tomohiro Ishikita; Keiko Koyama
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

4.  Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.

Authors:  T Kawamura; T Kusakabe; T Sugino; K Watanabe; T Fukuda; A Nashimoto; K Honma; T Suzuki
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

5.  Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival.

Authors:  C P Theuer; F Nastanski; W R Brewster; J A Butler; H Anton-Culver
Journal:  Am Surg       Date:  1999-10       Impact factor: 0.688

6.  Clinicopathological characteristics of signet ring cell carcinoma of the stomach.

Authors:  Dong Yi Kim; Young Kyu Park; Jae Kyoon Joo; Seong Yeob Ryu; Young Jin Kim; Shin Kon Kim; Jae Hyuk Lee
Journal:  ANZ J Surg       Date:  2004-12       Impact factor: 1.872

7.  Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.

Authors:  Bishnuhari Paudyal; Noboru Oriuchi; Pramila Paudyal; Tetsuya Higuchi; Takashi Nakajima; Keigo Endo
Journal:  Cancer Sci       Date:  2008-02       Impact factor: 6.716

8.  Changes in the location and type of gastric adenocarcinoma.

Authors:  D A Antonioli; H Goldman
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

9.  Advanced gastric carcinoma with signet ring cell histology.

Authors:  Chen Li; Sungsoo Kim; Ji Fu Lai; Woo Jin Hyung; Won Hyuk Choi; Seung Ho Choi; Sung Hoon Noh
Journal:  Oncology       Date:  2007-11-14       Impact factor: 2.935

10.  Signet ring cell carcinoma of the stomach.

Authors:  Y Maehara; Y Sakaguchi; S Moriguchi; H Orita; D Korenaga; S Kohnoe; K Sugimachi
Journal:  Cancer       Date:  1992-04-01       Impact factor: 6.860

View more
  5 in total

1.  Preoperative prediction of the pathological stage of advanced gastric cancer by 18F-fluoro-2-deoxyglucose positron emission tomography.

Authors:  Kota Yamada; Naoki Urakawa; Shingo Kanaji; Hiroshi Hasegawa; Masashi Yamamoto; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Sci Rep       Date:  2022-07-05       Impact factor: 4.996

Review 2.  Management of gastric cancer in Indian population.

Authors:  Mohammed Ibrahim; Kissan Gilbert
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-09

3.  Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential.

Authors:  Renjie Wang; Wenqiang Xiang; Ye Xu; Lingyu Han; Qingguo Li; Weixing Dai; Guoxiang Cai
Journal:  Ann Transl Med       Date:  2020-03

4.  Development of prognostic predictive model with neutrophil-lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma.

Authors:  Shihai Yang; Shangdong Li
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

5.  Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer.

Authors:  Chenqing Yin; Bin Gao; Ju Yang; Jingbo Wu
Journal:  Med Sci Monit Basic Res       Date:  2020-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.